A7284
Bovine Serum Albumin solution
30%±2% in 0.85% sodium chloride, aseptically filled
Synonym(s):
Albumin solution from bovine serum, BSA solution
biological source
bovine
Quality Level
sterility
aseptically filled
Assay
28-32% protein basis (biuret)
form
solution
purified by
heat shock fractionation
contains
0.1% sodium azide as preservative
does not contain
stabilizer
origin
USA origin
concentration
28-32% protein (biuret)
30%±2% in 0.85% sodium chloride
technique(s)
ELISA: suitable
UniProt accession no.
storage temp.
2-8°C
Gene Information
bovine ... ALB(280717)
Looking for similar products? Visit Product Comparison Guide
General description
Bovine serum albumin (BSA) is bound in a single chain cross-linked with 17 cysteine residues. It comprises three homologous, structurally different domains and two sub-domains each. This globular, α-helical, non-glycosylated protein is produced in the liver.
Application
Bovine Serum Albumin solution has been used:
- to study the effects of plasma protein on sulfated glycosaminoglycans (sGAGs)
- to histologically evaluate the implanted allogeneic mesenchymal stem cells (MSCs) alginate constructs
- as a component of phosphate-buffered saline (PBS) to treat red blood cells (RBC) for sample preparation
Biochem/physiol Actions
Bovine Serum Albumin (BSA) is the most widely used blocking agent in enzyme-linked immunosorbent assay (ELISA). It is also the main constituent of cell culture media. BSA promotes the differentiation of human embryonic stem cells (hESC) differentiation and assists the circulation of drugs, hormones, and fatty acids.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
含少量动物源组分生物产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Emily M Thrash et al.
STAR protocols, 1(2), 100055-100055 (2020-10-29)
As mass cytometry (MC) is implemented in clinical settings, the need for robust, validated protocols that reduce batch effects between samples becomes increasingly important. Here, we present a streamlined MC workflow for high-throughput staining that generates reproducible data for up
M J Leijs et al.
European cells & materials, 33, 43-58 (2017-02-01)
Bone marrow derived mesenchymal stem cells (MSCs) have immunomodulatory and trophic capacities. For therapeutic application in local chronic inflammatory diseases, MSCs, preferably of allogeneic origin, have to retain immunomodulatory properties. This might be achieved by encapsulation of MSCs in a
R Zhao et al.
Biorheology, 47(3-4), 193-203 (2010-11-19)
The accumulation of platelets near the blood vessel wall or artificial surface is an important factor in the cascade of events responsible for coagulation and/or thrombosis. In small blood vessels and flow channels this phenomenon has been attributed to the
Derry C Roopenian et al.
mAbs, 7(2), 344-351 (2015-02-06)
Serum albumin is the major determinant of blood colloidal osmotic pressure acting as a depot and distributor of compounds including drugs. In humans, serum albumin exhibits an unusually long half-life mainly due to protection from catabolism by neonatal Fc receptor
Brent L Wood
Current protocols in cytometry, 93(1), e73-e73 (2020-04-21)
The identification of residual leukemia following therapy, termed minimal or measurable residual disease (MRD), has emerged as one of the most important prognostic factors for patients with acute leukemia, including acute myeloid leukemia (AML). Flow cytometry is a preferred method
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service